<DOC>
	<DOCNO>NCT00940056</DOCNO>
	<brief_summary>Primary Objective To evaluate efficiency totally endoscopic ablation AF compare rate control management AF . Secondary Objectives Does totally endoscopic ablation : - reduce atrial fibrillation symptom ? - increase work capacity improve quality life ? - improve atrial function ? - reduce risk stroke ?</brief_summary>
	<brief_title>Totally Endoscopic Ablation Atrial Fibrillation</brief_title>
	<detailed_description>This randomize open control single centre study involve 60 patient ( men woman ) age 50 year longstanding persistent AF one year duration absence severe cardiopulmonary disease . One participate investigator informs patient , verbally write , study participation study involve . The patient give time ask question consider study participation enrol study sign date write Informed Consent . Study duration per patient 12 month . After inclusion , patient divide one two group , treatment group control group , accord block wise randomization . The patient ask complete two health relate questionnaire SF 36 SCL transthoracic echocardiography conduct together exercise test . The patient thereafter assess accord randomisation . Irrespective group , patient reschedule visit within two month totally endoscopic ablation Reveal implantation Reveal implantation ( control group ) . All patient assess follow-ups 1 , 3 , 6 12 month .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Age &gt; 50 year 2 . Longstanding persistent AF &gt; 1 year duration 3 . Severe symptom related AF 4 . Have sign date Informed Consent . 5 . Willing able comply protocol duration trial . 1 . Severe ischemic heart disease heart valve disease 2 . Thrombus formation leave atrial appendage 3 . Intolerance warfarin medication 4 . Advanced pulmonary disease , FEV 1 &lt; 1.5 litre 5 . Left atrial diameter &gt; 60 mm 6 . Body Mass Index ( BMI ) &gt; 35 kg/m2 7 . Previous pulmonary heart surgery 8 . Participation another clinical trial within last 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Atrial fibrillation</keyword>
	<keyword>Ablation</keyword>
	<keyword>Thoracoscopy</keyword>
	<keyword>Atrial function</keyword>
</DOC>